310 related articles for article (PubMed ID: 11054154)
1. Pre-clinical studies of pramipexole: clinical relevance.
Hubble JP
Eur J Neurol; 2000 May; 7 Suppl 1():15-20. PubMed ID: 11054154
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
Dooley M; Markham A
Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.
Piercey MF
Clin Neuropharmacol; 1998; 21(3):141-51. PubMed ID: 9617505
[TBL] [Abstract][Full Text] [Related]
4. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
Bennett JP; Piercey MF
J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
[TBL] [Abstract][Full Text] [Related]
5. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
Linazasoro G;
J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
[TBL] [Abstract][Full Text] [Related]
6. Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease.
Markham A; Benfield P
CNS Drugs; 1997 Apr; 7(4):328-40. PubMed ID: 27520755
[TBL] [Abstract][Full Text] [Related]
7. Ropinirole and pramipexole, the new agonists.
Hobson DE; Pourcher E; Martin WR
Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S27-33. PubMed ID: 10451757
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
[TBL] [Abstract][Full Text] [Related]
9. Switching from pergolide to pramipexole in patients with Parkinson's disease.
Hanna PA; Ratkos L; Ondo WG; Jankovic J
J Neural Transm (Vienna); 2001; 108(1):63-70. PubMed ID: 11261747
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Parkinson's disease should begin with a dopamine agonist.
Montastruc JL; Rascol O; Senard JM
Mov Disord; 1999 Sep; 14(5):725-30. PubMed ID: 10495032
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
Piercey MF; Hoffmann WE; Smith MW; Hyslop DK
Eur J Pharmacol; 1996 Sep; 312(1):35-44. PubMed ID: 8891576
[TBL] [Abstract][Full Text] [Related]
12. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease.
Radad K; Gille G; Rausch WD
Pharmacol Rep; 2005; 57(6):701-12. PubMed ID: 16382188
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of dopamine agonists in Parkinson's disease.
Lange KW
Drugs Aging; 1998 Nov; 13(5):381-9. PubMed ID: 9829165
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological profiles and clinical effects of antiparkinsonian agent, pramipexole].
Kohno Y; Takeuchi S
Nihon Yakurigaku Zasshi; 2004 Jun; 123(6):429-40. PubMed ID: 15170083
[TBL] [Abstract][Full Text] [Related]
15. New pharmacotherapy for Parkinson's disease.
Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.
Deleu D; Northway MG; Hanssens Y
Clin Pharmacokinet; 2002; 41(4):261-309. PubMed ID: 11978145
[TBL] [Abstract][Full Text] [Related]
17. Dopamine agonist monotherapy in Parkinson's disease.
Clarke CE; Guttman M
Lancet; 2002 Nov; 360(9347):1767-9. PubMed ID: 12480442
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonists: the treatment for Parkinson's disease in the XXI century?
Lledó A
Parkinsonism Relat Disord; 2000 Nov; 7(1):51-58. PubMed ID: 11008196
[TBL] [Abstract][Full Text] [Related]
19. Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Le WD; Jankovic J
Drugs Aging; 2001; 18(6):389-96. PubMed ID: 11419913
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonists.
Factor SA
Med Clin North Am; 1999 Mar; 83(2):415-43, vi-vii. PubMed ID: 10093586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
